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a b s t r a c t
Lupus mesenteric vasculitis (LMV) is a rare cause of acute abdominal pain. Few cases of 
LMV have been reported in adults, children and adolescents. However, to our knowledge, 
the prevalence of that severe vasculitis in a pediatric population with lupus is yet to be 
studied. This study reviewed data from 28 consecutive years and included 5,508 patients 
being followed up at the hospital of the Faculdade de Medicina of the Univesidade de São 
Paulo (FMUSP). We identifi ed 279 (5.1%) patients meeting the American College of Rheuma-
tology classifi cation criteria for the diagnosis of systemic lupus erythematosus (SLE), one 
of whom (0.4%) had LMV. That male patient was diagnosed with SLE at the age of 11 years. 
At the age of 13 years, he was hospitalized with diffuse and acute abdominal pain, nausea, 
bilious vomiting, abdominal distension, rebound tenderness, and abdominal muscle guard-
ing. The patient underwent laparotomy immediately, and segmentary intestinal ischemia 
with intestinal wall edema and adhesions were identifi ed. Partial small bowel resection 
with lysis of the adhesions was performed, as were pulses of intravenous methylpredniso-
lone. The histopathologic analysis evidenced mesenteric arteritis. After 13 days, the diffuse 
and intense abdominal pain recurred, and the patient underwent a new laparotomy, dur-
ing which adhesive small bowel obstruction with intestinal gangrene was identifi ed. New 
intestinal resection was performed, and the patient received pulses of intravenous meth-
ylprednisolone and infusion of immunoglobulin. Thus, LMV is a rare and severe abdominal 
manifestation of the pediatric population with lupus, and can be the only manifestation of 
disease activity. In addition, this study stresses the importance of the early diagnosis and 
immediate treatment. 
© 2013 Elsevier Editora Ltda. All rights reserved.
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Vasculite mesentérica em paciente com lúpus eritematoso sistêmico juvenil
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r e s u m o
A vasculite mesentérica lúpica (VML) é uma rara causa de dor abdominal aguda. Há poucos 
relatos de caso demonstrando VML em adultos e, particularmente, em crianças e adoles-
centes. No entanto, para o nosso conhecimento, a prevalência dessa grave vasculite em uma 
população pediátrica com lúpus ainda não foi estudada. Portanto, dados de 28 anos conse-
cutivos foram revisados e incluídos 5.508 pacientes em seguimento no Hospital da Facul-
dade de Medicina da Univesidade de São Paulo (FMUSP). Identifi camos 279 (5,1%) casos que 
preencheram critérios de classifi cação diagnóstica do American College of Rheumatology 
para lúpus eritematoso sistêmico (LES) e um (0,4%) desses apresentou VML. Este paciente 
recebeu diagnóstico de LES aos 11 anos de idade. Aos 13 anos foi hospitalizado com dor 
abdominal difusa e aguda, náuseas, vômitos biliosos, distensão e rigidez abdominal, com 
descompressão brusca positiva. O paciente foi prontamente submetido à laparotomia ex-
ploradora, identifi cando isquemia intestinal segmentar, com edema de parede intestinal e 
aderências. Foi realizada ressecção parcial de intestino delgado, com lise das aderências e 
pulsoterapia com metilprednisolona. A análise histopatológica identifi cou arterite de vasos 
mesentéricos. Após 13 dias, apresentou recorrência de dor abdominal difusa intensa, sendo 
novamente submetido à laparotomia exploradora, identifi cando obstrução em intestino 
delgado por aderências, com gangrena intestinal. Nova ressecção intestinal foi realizada, 
além de pulsoterapia com metilprednisolona e infusão de imunoglobulina. Portanto, VML é 
uma rara e grave manifestação abdominal na população com lúpus pediátrico, e pode ser a 
única manifestação de atividade da doença. Além disso, este estudo reforça a importância 
do diagnóstico precoce e do tratamento imediato. 
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Systemic lupus erythematosus (SLE) may affect multiple or-
gans and systems, such as gastrointestinal involvement.1,2 
Digestive tract manifestations in SLE patients are generally 
caused by treatment related to adverse events, infections,3 
and disease activity.2,4
Of note, lupus mesenteric vasculitis (LMV) is a cause of 
acute abdominal pain, associated with nausea, vomiting, 
diarrhea in SLE patients usually with disease activity.4 The 
diagnosis of LMV requires the evaluation of bowel wall and 
the abdominal vasculature by image examination,4 such as 
abdominal ultrasound,3,5,6 computer tomography scan,3,7,8 
magnetic resonance image,6 digital arteriography,8 and/or 
particularly histopathological fi ndings.4
A few case reports have demonstrated LMV in adult 
SLE7,8,10 and particularly in juvenile SLE (JSLE) patients.5,6,9,10 
However, to our knowledge, the prevalence of this severe 
vasculitis in paediatric lupus population has not been 
studied.
Therefore, from January 1983 to December 2010, 5,508 pa-
tients were followed-up at the Paediatric Rheumatology Unit 
of the Instituto da Criança, Hospital das Clínicas, Faculdade 
de Medicina, Universidade de São Paulo (ICr-HC-FMUSP) and 
279 (5%) of them were acquainted to the American College 
of Rheumatology (ACR)11 classifi cation criteria for SLE. Only 
one (0.4%) of our JSLE patients had LMV, confi rmed by the 
description of histopathological fi ndings and required intes-
tinal resections. This study was approved by the Local Ethics 
Committee of FMUSP.
Case report
An 11-year old boy was diagnosed with JSLE based on ma-
lar rash, arthritis, pericarditis, psychosis, lymphopenia, and 
thrombocytopenia, and positivity of the following autoanti-
bodies: antinuclear antibodies (ANA) 1:1280 (speckled pat-
tern), anti-Sm, and anti-double stranded DNA (anti-dsDNA) 
antibodies. At that moment, the SLE Disease Activity Index 
2000 (SLEDAI-2K)12 was 19 and he received three pulses of 
intravenous methylprednisolone, intravenous cyclophos-
phamide (500–1,000 mg/m2/month for 24 months) and pred-
nisone (2.0  mg/kg/day), with progressive dose decrease to 
7.5 mg/day. At the age of 13, he was hospitalized due to an 
acute diffuse abdominal pain, nausea and bilious vomiting. 
On physical examination, he had abdominal distension, re-
bound tenderness and abdominal muscle guarding, compat-
ible with acute surgical abdomen. At that moment, he was 
under 7.5 mg/day of prednisone and abdominal ultra-sound 
examination showed mild ascites, diffuse distension and 
bowel-wall thickening. Laboratory tests showed hemoglobin 
13.5 g/L, hematocrit 40%, white blood cell count 5,400/mm3 
(72% neutrophils, 21% lymphocytes, 4% eosinophils and 3% 
monocyte), platelets 265,000/mm3, proteinuria (0.02  g/24h), 
urinalysis – leukocytes 500 high-power fi eld, and erythro-
cytes 250 high-power fi eld, urea 19 mg/dL (normal range 10–
42), creatinine 0.5 mg/dL (normal range 0.5–0.9), C3 0.86 mg/
dL (normal range 0.5–1.8), C4 0.13 mg/dL (normal range 0.1–
0.4), and amylases 46 U/L (normal < 106 U/L). The erythrocyte 
sedimentation rate was 42 mm in the fi rst hour. Immunolog-
ical tests revealed negative for anti-dsDNA, lupus anticoagu-
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lant, and IgG and IgM anticardiolipin antibodies. The patient 
immediately underwent a laparotomy and segmental edema 
with adhesions and small bowel infarctions were identi-
fi ed. Partial small bowel resection (4 cm vs. 2.5 cm) was per-
formed with lysis of adhesions. The histopathology showed 
submucosa edema with a diffuse infl ammatory infi ltrate of 
mononuclear cells, and mesenteric vessels arteritis. At that 
moment, his SLEDAI-2K12 was 8 and he received three pulses 
of intravenous methylprednisolone. After four days, he was 
transferred to out-patient clinic of FMUSP receiving 10 mg/
day of prednisone. Thirteen days later, he had recurrence 
of severe and diffuse abdominal pain and distension, with 
bilious vomiting and acute diarrhea. A plain radiography of 
the abdomen showed diffuse bowel distension with air-fl uid 
level compatible to partial intestinal occlusion. The patient 
was promptly submitted to a new laparotomy which identi-
fi ed adhesive small bowel obstruction with intestinal gan-
grene. Remarkably, resections of 12 cm vs. 6.5 cm of small 
bowel and 12 cm vs. 7 cm of caecum, lysis of adhesions and 
terminal ileostomy were also performed. At that moment, 
he received three pulses of intravenous methylprednisolone 
and a single infusion of intravenous immunoglobulin (2 g/
kg/day), followed by 10 mg/day of prednisone, with rapid re-
covery and improvement of his gastrointestinal symptoms. 
At 13.5 years, loop ileostomy closure was carried out and the 
SLEDAI-2K12 was 0. The Systemic Lupus International Col-
laborating Clinics of the American College of Rheumatology 
– Damage Index (SLICC/ACR-DI)13 was 2 and he was receiv-
ing prednisone 5 mg/day. No complications after intestinal 
resections were observed.
 Discussion
We described a case of LMV followed at the tertiary Paediat-
ric University Hospital that evidenced the rare occurrence of 
this severe vasculitis as a cause of permanent disease dam-
age. Moreover, this complication required multiple intestinal 
resections without late bowel complications.
LMV in adult patients has been reported from 0.2% to 
9.7%,3,4,8 with very few cases described in paediatric lupus 
population.5,6,10,14 This complication is a life-threatening ab-
dominal manifestation characterized by bowel ischemia, with 
high mortality rates up to 50%.3,4,8 Usually, the abdominal pain 
triggered by LMV shows a diffuse pattern and is generally 
associated with nausea, vomiting, diarrhea, abdominal dis-
tension, rebound tenderness and abdominal muscle guard-
ing,3,4,6–8 as observed in this case . In addition, the occurrence 
of acute abdomen that required intestinal resections was 
rarely reported in lupus adolescent population,14 as also evi-
denced herein.
The signs and symptoms of LMV are non-specifi c, and ra-
diological investigations3,4,6,8 or pathological fi ndings3,4,6 are 
necessary to confi rm the diagnosis. Abdominal ultrasonogra-
phy can demonstrate small intestinal edema and thickening 
of the bowel-wall.3 In fact, the patient’s ultrasound revealed 
mild ascites, diffuse distension and bowel-wall thickening. 
Remarkably, the LMV histopathology evidences sub-mucosal 
edema, diffuse infl ammatory infi ltrate of mononuclear cells, 
and both small vessel arteritis and venulitis.4 
Generally lupus patients with mesenteric vasculitis have 
active disease with high SLEDAI scores,4,7,8 associated with 
nephritis,6,7,8 neuropsychiatric involvement,6 and/or hema-
tological abnormalities.7 The presence of LMV with low dis-
ease activity was rarely described.6 The pathogenesis of LMV 
is unknown, but it is suggested that it involves a vasculitis 
with immune-complex deposition and/or intestinal vessels 
thrombosis3 leading to mesenteric ischemia.3,4 Autoantibod-
ies, such as antiphospholipid and anti-endothelial cell anti-
bodies, may also contribute in the immunopathogenesis of 
this complication.3,4
Of note, LMV requires prompt diagnose and appropriate 
treatment with corticosteroids,15 particularly intravenous infu-
sion of methylprednisolone, and immunosuppressive therapy 
in non-responsive cases.3,4,6–8 The patient was previously treat-
ed with intravenous cyclophosphamide, therefore, we used in-
travenous immunoglobulin associated with corticosteroid. 
Furthermore, as utilized in this present case, early surgical 
treatment should be indicated in JSLE patients with extensive 
bowel ischemia and/or perforation, reducing the risk of mor-
bidity and mortality.3,4,6 The patient had an additional com-
plication with adhesive small bowel obstruction and intesti-
nal infarction, requiring extensive bowel resections without 
any further complications, possible related to low prednisone 
dose after the fi rst surgery. Moreover, corticosteroids have al-
ready been tested for the prevention of abdominal adhesions 
caused by surgical procedures, with limited results.16 
In conclusion, LMV should be evaluated in all children and 
adolescents with acute abdominal pain and may be an iso-
lated manifestation of lupus activity. This study reinforces the 
importance of early diagnosis and prompt treatment for this 
severe gastrointestinal vasculitis. 
Financial support
FAPESP (grant 08/58238-4 to CAS), CNPQ (300248/2008-3 to 
CAS) and Federico Foundation (to CAS).
Confl icts of interest
The authors declare no confl icts of interest. 
R E F E R E N C E S
1. Faco MM, Leone C, Campos LM, Febrônio MV, Marques HH, 
Silva CA. Risk factors associated with the death of patients 
hospitalized for juvenile systemic lupus erythematosus. Braz 
J Med Biol Res. 2007;40(7):993-1002.
2. Campos LM, Omori CH, Lotito AP, Jesus AA, Porta G, Silva CA. 
Acute pancreatitis in juvenile systemic lupus erythematosus: 
a manifestation of macrophage activation syndrome? Lupus. 
2010;19(14):1654-8.
3. Tian XP, Zhang X. Gastrointestinal involvement in systemic 
lupus erythematosus: insight into pathogenesis, diagnosis 
and treatment. World J Gastroenterol. 2010;16(24):2971-7.
4. Ju JH, Min JK, Jung CK, Oh SN, Kwok SK, Kang KY, et al. Lupus 
mesenteric vasculitis can cause acute abdominal pain in 
patients with SLE. Nat Rev Rheumatol. 2009;5(5):273-81.
R E V  B R A S  R E U M A T O L .  2 0 1 3 ; 5 3 ( 2 ) : 2 1 9 – 2 2 2222
5. Meyers KE, Pfi effer S, Lu T, Kaplan BS. Genitourinary 
complications of systemic lupus erythematosus. Pediatr 
Nephrol. 2000;14(5):416-21.
6. Tu YL, Chen LC, Ou LH, Huang JL. Mesenteric vasculitis as 
the initial presentation in children with systemic lupus 
erythematosus. J Pediatr Gastroenterol Nutr. 2009;49(2):251-3.
7. Chen SY, Xu JH, Shuai ZW, Wang MQ, Wang F, Xu SQ, et al. 
A clinical analysis 30 cases of lupus mesenteric vasculitis. 
Zhonghua Nei Ke Za Zhi. 2009;48(2):136-9.
8. de Carvalho JF. Mesenteric vasculitis in a systemic lupus 
erythematosus patient with a low sledai: an uncommon 
presentation. Clinics (São Paulo). 2010;65(3):337-40.
9. Hermann G. Intussusception secondary to mesenteric arteries. 
Complication of systemic lupus erythematosus in a 5-year-old 
child. JAMA. 1967;200(1):74-5. 
10. Tu YL, Yeh KW, Chen LC, Yao TC, Ou LS, Lee WI, et al. 
Differences in disease features between childhood-onset and 
adult-onset systemic lupus erythematosus patients presenting 
with acute abdominal pain. Semin Arthritis Rheum. 
2011;40(5):447-54. 
11. Hochberg MC. Updating the American College of Rheumatology 
revised criteria for the classifi cation of systemic lupus 
erythematosus. Arthritis Rheum. 1997;40(9):1725. 
12. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus 
erythematosus disease activity index 2000. J Rheumatol. 
2002;29(2):288-91.
13. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz 
M, et al. The development and initial validation of the 
Systemic Lupus International Collaborating Clinics/American 
College of Rheumatology damage index for systemic lupus 
erythematosus. Arthritis Rheum. 1996;39(3):363-9.
14. Turner HE, Myszor MF, Bradlow A, David J. Lupus or lupoid 
hepatitis with mesenteric vasculitis. Br J Rheumatol. 
1996;35(12):1309-11.
15. Marinello DK, Rafael D, Paiva Edos S, Dominoni RL. Systemic 
lupus erythematosus complicated by intestinal vasculitis and 
pneumatosis intestinalis. Rev Bras Reumatol. 2010;50(5):596-602.
16. Attard JA, MacLean AR. Adhesive small bowel obstruction: 
epidemiology, biology and prevention. Can J Surg. 
2007;50(4):291-300.  
